HOME >> MEDICINE >> NEWS
New research brings initial find of Alois Alzheimer to fore once again

The two dominant proteins that determine how much blood flows through the body's arteries have been implicated in Alzheimer's disease, in a new study in the Jan. 16 issue of the Proceedings of the National Academy of Sciences. They offer new, surprising targets against Alzheimer's disease just as scientists are getting back in touch with the vascular roots of the disease that were first recognized early last century.

The research, putting proteins often linked to heart disease front and center in a brain disease whose causes remain a mystery, hark back to what German physician Alois Alzheimer noted when he first recognized the disease 100 years ago. Though Alzheimer noted changes in both the brain's cells and in the small arteries and capillaries that supply and drain blood to and from the brain, over the decades doctors separated the two concepts and have come to focus mainly on the toxic effects of the disease on cells. The changes to blood vessels have been pushed to the background.

The latest findings from the University of Rochester Medical Center mesh not only with Dr. Azheimer's initial observations but also with new findings from today's best imaging technologies. While the first visible symptom of Alzheimer's may be a person forgetting names or faces, the very first physical change is actually a decline in the amount of blood that flows in the brain. Doctors have found that not only is blood flow within the brain reduced, but that the body's capacity to allocate blood to different areas of the brain on demand is blunted in people with the disease.

"A reduction in blood flow precedes the decline in cognitive function in Alzheimer's patients," said Berislav Zlokovic, M.D., Ph.D., professor in the Department of Neurological Surgery and a neurovascular expert whose research is causing scientists to consider the role of reduced blood flow in Alzheimer's disease.

"People used to say, well, the brain is atrophying becaus
'"/>

Contact: Tom Rickey
tom_rickey@urmc.rochester.edu
585-275-7954
University of Rochester Medical Center
22-Jan-2007


Page: 1 2 3 4

Related medicine news :

1. 1 of 2 pediatric kidney disease research centers in world established
2. Stanford researchers find culprit in aging muscles that heal poorly
3. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
4. Indiana University Imaging Center receives $6M grant for kidney research
5. Penn researchers discover novel pathway for increasing good cholesterol
6. New research discovers independent brain networks control human walking
7. Theory of facial aging gets a facelift from UT Southwestern researchers
8. Sports concussion research using fMRI provides insight for safe return-to-play decisions
9. UIC researchers to develop new drugs to fight bioterrorism
10. New research finds high prevalence of smoking among physicians in China
11. Fat is the new normal, FSU researcher says

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New research brings initial find Alois Alzheimer fore once again

(Date:8/4/2015)... ... August 05, 2015 , ... Renowned review site BestMillionaireDatingSites.com recently refreshed ... update, MillionaireMatch.com has been ranked as the best dating service in the segment. , ... life companion. It is essential that people find the right dating platform so that ...
(Date:8/4/2015)... ... ... How cool is it to check in at your favorite place and be ... soon allow you to do just that. , Ahhaa is releasing the next version ... , Users will soon get to share what inspires them about their favorite places ...
(Date:8/4/2015)... ... August 04, 2015 , ... Sponsored by Gila River Casinos, the charity ... 501(c) nonprofit organization. , According to the New Foundation AZ spokesperson , the ... package that includes a complimentary foursome for the tournament, as well as getting their ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... technology platform that uses Cloud innovation to consolidate oncology patient assistance programs. Through ... a single point of access. assistPoint is an enterprise level, cloud-based application and ...
(Date:8/4/2015)... ... ... Rhode Island Medical Imaging (RIMI) is pleased to announce the opening of ... Road in Lincoln, RI. This satellite office will provide x-ray and ultrasound exams. ... hours in the state, which includes evenings and weekends. , “This satellite office ...
Breaking Medicine News(10 mins):Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:assistPoint.com Web Site Launched 2Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2
(Date:8/4/2015)... SOUTHAMPTON , England ... Ltd (ASX: PXS) and UK biotechnology company Synairgen plc (LSE: ... to develop a selective inhibitor to the lysyl oxidase type ... pulmonary fibrosis (IPF). IPF affects in the ... expected to produce global revenues in excess of $1.1 billion ...
(Date:8/4/2015)... -- On August 3, 2015, a press conference on anti-virus ... donation ceremony of a million masks by Wuhan Longfeixiang Technology ... . Wuhan Longfeixiang Technology ... Hubei Longfeixiang Industrial Group, which has successfully developed the ... anti-pollution mask, filling the global gap for masks of ...
(Date:8/4/2015)... ALGONQUIN, Ill. , Aug. 4, 2015 /PRNewswire/ ... of dental supplies and equipment, today announced the ... of Medical Products Laboratories, Inc. ("MPL PDCMD"). MPL ... materials used in preventive and restorative dental procedures. ... strategic expansion of our business in attractive, high-growth ...
Breaking Medicine Technology:Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2
Cached News: